Spike Pharmaceuticals set out to explore a new sales model
Release time:
2020-08-14
agent and terminal link production and chain cooperation
peak pharmaceutical industry began to explore a new sales model
news 8# October 16 to 21 , the 2017 China Pharmaceutical Retail Industry Information Conference (hereinafter referred to as "Xi Pu Conference") with the theme of "Building a Blueprint-Market Awakening Focusing on Demand" was held in Boao, Hainan. Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, and relevant responsible persons such as Jianfeng Health, Pharmaceutical Sales Company and Jianfeng Pharmacy were invited to attend the conference to create a new sales model "exploring way".
This year coincides with the 10th anniversary of the Western Conference. More than 20 1200 mainstream chain pharmacies, more than 22 800 brand pharmaceutical industries, more than 24 100 cross-border affiliated institutions, more than 26 130 top capital institutions at home and abroad, more than 28 60 representatives of authoritative media, and authoritative experts in the industry, nearly 30 4000 people gathered in Boao. The meeting combed the context of the pharmaceutical retail industry in the past ten years, discussed the development of the industry in the new decade, and built a new blueprint for the industry. During the meeting, Huang Jinlong led the peak participants to have in-depth exchanges with the leaders of the conference organizers and industry experts on the impact of national policies such as corporate brand strategy, the role of brand enterprises in the industry, medical reform, prescription outflow and other issues on the original sales model of pharmaceutical enterprises. He also had extensive contact with pharmaceutical counterparts and terminal chains, listened to front-line sales experience and collected relevant information on terminal chains, bring together the top 100 chain market dynamics. In the past ten years, the retail scale of drugs in China has increased from 1430
3377 .1 billion yuan, and the chain rate has increased from
to 49.4% , playing an increasingly important role in the self-medication and drug accessibility of the masses. With the trend of prescription outflow becoming clear, drug retail terminals are playing an increasingly important role in the national medical and health system, but the overall size of the top 100 retailers is still hovering around 34% of the total drug retail industry, which shows that there is still huge room for market concentration. Before the expected trillion-dollar market, Peak Pharmaceutical Sales Company set up a new sales control department, trying to further extend the original sales channels into the terminal chain market and explore new sales models. The relevant person in charge of Jianfeng Pharmaceutical said that in the current complex and changeable market environment, pharmaceutical sales have also given birth to many new models. The establishment of a sales control department is an attempt to seamlessly link the agent and terminal models., To more effectively grasp the terminal dynamics of the pharmaceutical market, to achieve the purpose of sorting out channels, controlling channels and terminals, and then to increase drug sales in a good market environment, to improve the core competitiveness of enterprises, more is to do the sustainable sales "growth" of products, build a brand system, create a 360 brand marketing promotion model, and open a new exploration of win-win cooperation with the terminal chain market. (Xu Yuting)
More information
The company won the Taurus Award
On December 29, 2022, the "2022 High-quality Development Forum of listed companies and the 24th Golden Bull Award presentation ceremony of listed companies" jointly sponsored by China Securities News, Haikou Municipal Government and Haikou National High-tech Zone was held in Haikou. The list of Golden Bull Awards of listed companies was officially announced. With its outstanding performance, Jianfeng Group won the "2021 Golden Bull Most Investment Value Award".
2023
01-12
From December 11th to 12th, the 13th National Congress of the All-China Federation of Industry and Commerce was held in Beijing. Jiang Xiaomeng, chairman of the group company, attended the conference as a representative of Zhejiang.
2022
12-22
Yunnan Jianfeng won the title of "Harmonious Labor Relations Enterprise" in Yunnan Province
On November 18, the Yunnan Provincial Federation of Trade Unions, the Department of Human Resources and Social Security, the Entrepreneur Association and other units jointly issued a document to commend the harmonious labor relations enterprises in Yunnan Province from 2020 to 2021. Yunnan Jianfeng Cement Company is on the list and is the only enterprise in the urban area of Pu'er to receive this honor.
2022
12-13
Huang Ping Jianfeng won the title of "provincial green factory" in Guizhou
On November 30, the Guizhou Provincial Department of Industry and Information Technology released the 2022 list of green manufacturing units in Guizhou Province, and Huangping Jianfeng Cement Company was recognized as a "provincial green factory".
2022
12-13
On December 2, Yu Jianhong, general manager of the group company, gave a management lesson to the company's reserve management talents under the title of "Enterprise Management Innovation in Great Changes.
2022
12-13
On November 24, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, gave a special party lesson to all party members and cadres of the company under the title of "comprehensively promoting the Great Rejuvenation of the Chinese Nation with Chinese Modernization" to interpret and preach the spirit of the 20th CPC National Congress.
2022
12-04
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page